Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
Status:
Completed
Trial end date:
2011-05-17
Target enrollment:
Participant gender:
Summary
RATIONALE: Lorazepam, diphenhydramine hydrochloride, and haloperidol gel, when absorbed into
the skin, may be an effective treatment for nausea and vomiting.PURPOSE: This clinical trial
studies lorazepam, diphenhydramine hydrochloride, and haloperidol gel in healthy volunteers.
Phase:
N/A
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborators:
American Cancer Society, Inc. National Cancer Institute (NCI)